A conference call is scheduled for Wednesday to discuss quarterly numbers and the status of the trial. It looks like the trial was completed a month or so ago, and it is hard to imagine that the Company does not know how it went. Frankly, I tend to think that Roth and Oppenheimer have been privy to "unofficial" information as well.
I am very long the stock, so perhaps this is just wishful thinking. But it is not so long ago that the stock was trading at $9, and, if anything, the story has gotten better.
It will be interesting to see what happens on Monday.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.